Daiichi Sankyo Europe Gmbh
Manufacturer / marketing-authorisation holder
Daiichi Sankyo Europe Gmbh — 21 products across 2 markets, 7 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Daiichi Sankyo Europe Gmbh — 21 productos en 2 mercados, 7 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Daiichi Sankyo Europe Gmbh —— 共 21 个产品,覆盖 2 个市场、7 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
21 products · 2 markets · 7 brand names
21 productos · 2 mercados · 7 marcas
21 个产品 · 2 个市场 · 7 个品牌名
Products by country
ES
Source: cima.aemps.es
| Brand | Active ingredient(s) | Form |
|---|---|---|
| DATROWAY | Datopotamab Deruxtecan | injection |
| Enhertu | Trastuzumab Deruxtecan | injection |
| Enhertu | Trastuzumab Deruxtecan | injection |
| Enhertu | Trastuzumab Deruxtecan | injection |
| Lixiana 15mg tablets | 甲苯磺酸艾多沙班 | tablet |
| Lixiana 15mg tablets | 甲苯磺酸艾多沙班 | tablet |
| Lixiana 15mg tablets | 甲苯磺酸艾多沙班 | tablet |
| Lixiana 15mg tablets | 甲苯磺酸艾多沙班 | tablet |
| Lixiana 15mg tablets | 甲苯磺酸艾多沙班 | tablet |
| Nilemdo 180mg tablets | Bempedoic Acid | tablet |
| Nustendi 180mg/10mg tablets | Bempedoic Acid + 依折麦布 | tablet |
| VANFLYTA | Quizartinib | tablet |
| VANFLYTA | Quizartinib | tablet |
EU
Source: www.ema.europa.eu
| Brand | Active ingredient(s) | Form |
|---|---|---|
| DATROWAY | Datopotamab Deruxtecan | unknown |
| Enhertu | Trastuzumab Deruxtecan | unknown |
| Lixiana 15mg tablets | 甲苯磺酸艾多沙班 | unknown |
| Nilemdo 180mg tablets | Bempedoic Acid | unknown |
| Nustendi 180mg/10mg tablets | Bempedoic Acid + 依折麦布 | unknown |
| Turalio | Pexidartinib | unknown |
| VANFLYTA | Quizartinib | unknown |
| VANFLYTA | Quizartinib | unknown |